FTC alleges CVS's PBM manipulated insulin prices.
Proposed deal aims to improve access to affordable insulin.
Settlement could significantly reduce costs for consumers.
FTC alleges CVS's PBM manipulated insulin prices.
Proposed deal aims to improve access to affordable insulin.
Settlement could significantly reduce costs for consumers.